According to the Univdatos, the rise in prevalence of cancer, and HIV, increasing penetration of CXCR4 antagonists, expansion of combination therapy, and increasing focus towards research and development drive the CXCR4 antagonist market. As per their “CXCR4 antagonists Market” report, the global market was valued at USD 507.04 million in 2023, growing at a CAGR of about 12.37%...
According to the Univdatos, the rise in prevalence of osteoporosis, growing advancements in medical devices, and increasing focus on preventive measures drive the bone sonometer market. As per their “Bone Sonometer Market” report, the global market was valued at USD 1,178.5 million in 2023, growing at a CAGR of about 5.7% during the forecast period from 2024 - 2032 to reach USD...
According to the Univdatos, the increased prevalence of PTC, and the rising healthcare expenditures drive the pseudotumor cerebri market. As per their “Pseudotumor cerebri Market” report, the global market was valued at USD ~3.2 billion in 2023, growing at a CAGR of about 5.5% during the forecast period from 2024 - 2032 to reach USD billion by 2032.
Introduction
Pseudotumor cerebri,...
According to the Univdatos, the rise in prevalence of cancer, and infectious diseases, increasing demand for gene therapies, expansion of combination therapy, and increasing focus towards research and development drive the Plasmid DNA manufacturing market. As per their “Plasmid DNA Manufacturing Market” report, the global market was valued at USD 521.54 million in 2023, growing at a...
According to the Univdatos, the rise of prevalence of mpox, increasing mpox vaccination, government support, and increasing focus towards preventive measures drive the mpox treatment market. As per their “Mpox Treatment Market” report, the global market was valued at USD 1,025.46 million in 2023, growing at a CAGR of about 10.86% during the forecast period from 2024 - 2032 to reach...
English
Arabic
עברית
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek